A teardrop.
A measurable signal.
An electrochemical sensing approach being developed for quantitative tear fluid biomarker analysis.
See the approach
Built around
the detail.
A simplified overview of the development approach, not a clinical testing protocol.
Start with tear fluid
A small biological sample is the focus of the platform’s research.
Measure with a sensor
Electrochemical sensing with proprietary coatings forms the technology basis.
Bring biomarkers into focus
Current company materials discuss MMP-9 and tear film osmolarity.
Making the subjective
more measurable.
The company’s development aims include more quantitative insight for dry eye assessment. Broader disease applications remain research opportunities, not established indications.
Read official frequently asked questions
Useful insight starts with careful science.
Explore the
next question.
This concept does not imply regulatory clearance or commercial availability. Contact InnSight for current status.
Talk with the teamFollow the evidence.
Read the research documents linked by InnSight on its official website. These papers provide research context; they do not establish current product clearance.
Scientific Reports paper ↗Additional company-linked research ↗
View the official OcuCheck video ↗
